(FBT) First Trust NYSE Arca - Ratings and Ratios

The First Trust NYSE Arca Biotechnology Index Fund, traded on the NYSE Arca under the ticker symbol FBT, is an exchange-traded fund (ETF) that typically allocates at least 90% of its net assets to the securities that make up its underlying index. This index is specifically designed to track the performance of 30 prominent biotechnology companies, with each company being assigned an equal-dollar weight. This weighting approach ensures that the index provides a balanced representation of the biotechnology sector, rather than being dominated by a few large-cap companies.

The fund's investment strategy is focused on providing investors with exposure to the biotechnology industry, which encompasses a broad range of companies involved in the research, development, and commercialization of new medical treatments, drugs, and technologies. By investing in the securities of these 30 leading biotechnology companies, the fund offers a diversified portfolio that can help investors capitalize on the growth potential of this sector. The fund is managed by First Trust, a well-established investment management company with a strong track record of managing index-based ETFs. More information about the fund and its investment strategy can be found on the company's website at http://www.ftportfolios.com/.

From a structural perspective, the First Trust NYSE Arca Biotechnology Index Fund is a US-domiciled ETF, listed on the NYSE Arca, with the ISIN code US33733E2037. As an ETF, it is designed to provide investors with the benefits of trading flexibility, transparency, and diversification, while also offering a cost-effective way to gain exposure to the biotechnology sector. The fund falls under the health care category, which includes a wide range of ETFs and index funds that track the performance of companies involved in the health care and biotechnology industries.